Corbus制药控股(CRBP.US)

最近更新时间 19:00:00 美东
longbridge loading

Corbus 制药控股公司的股票在周二的表现逊于竞争对手

MarketWatch Automated·
US
Corbus制药控...
+6.34%
US
医药突破 ETF...
+3.75%
US
标普生物技术...
+3.88%
MarketWatch Automated·
US
Corbus制药控...
+6.34%
US
医药突破 ETF...
+3.75%
US
标普生物技术...
+3.88%

Corbus 制药控股公司的股票在周一的表现逊于竞争对手

MarketWatch Automated·
US
Corbus制药控...
+6.34%
US
标普生物技术...
+11.76%
US
IBBQ
+2.43%
MarketWatch Automated·
US
Corbus制药控...
+6.34%
US
标普生物技术...
+11.76%
US
IBBQ
+2.43%

Corbus 制药控股（CRBP）被 LifeSci Capital 给予买入评级

Tip Ranks·
US
Corbus制药控...
+6.34%
US
标普生物技术...
+3.88%
US
IBBQ
+2.43%
Tip Ranks·
US
Corbus制药控...
+6.34%
US
标普生物技术...
+3.88%
US
IBBQ
+2.43%

Corbus 制药控股公司的股票在周五的表现逊于竞争对手

MarketWatch Automated·
US
Corbus制药控...
+6.34%
US
医药突破 ETF...
+3.75%
US
动态生物技术...
+1.60%
MarketWatch Automated·
US
Corbus制药控...
+6.34%
US
医药突破 ETF...
+3.75%
US
动态生物技术...
+1.60%

Corbus 制药控股公司的股票在周四的表现逊于竞争对手

MarketWatch Automated·
US
Corbus制药控...
+6.34%
US
生物科技 ETF...
+0.96%
US
IBBQ
+2.43%
MarketWatch Automated·
US
Corbus制药控...
+6.34%
US
生物科技 ETF...
+0.96%
US
IBBQ
+2.43%

经纪商对 Corbus Pharma 第二季度收益的预测

Market Beat·
US
Corbus制药控...
+6.34%
US
动态生物技术...
+1.60%
US
2 倍做多纳斯...
+4.98%
Market Beat·
US
Corbus制药控...
+6.34%
US
动态生物技术...
+1.60%
US
2 倍做多纳斯...
+4.98%

RBC 资本重申对 Corbus 制药控股（CRBP）的买入评级

Tip Ranks·
US
Corbus制药控...
+6.34%
US
纽交所高增长...
+2.14%
US
纳斯达克生物...
+2.27%
Tip Ranks·
US
Corbus制药控...
+6.34%
US
纽交所高增长...
+2.14%
US
纳斯达克生物...
+2.27%

Corbus 制药控股公司的股票在一个强劲的交易日中表现优于竞争对手

MarketWatch Automated·
US
Corbus制药控...
+6.34%
US
2 倍做多纳斯...
+4.98%
US
纳斯达克生物...
+2.27%
MarketWatch Automated·
US
Corbus制药控...
+6.34%
US
2 倍做多纳斯...
+4.98%
US
纳斯达克生物...
+2.27%
© 2026 Longbridge｜免责声明